Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences

The ongoing COVID-19 pandemic highlights the need to tackle viral variants, expand the number of antigens, and assess diverse delivery systems for vaccines against emerging viruses. In the present study, a DNA vaccine candidate was generated by combining in tandem envelope protein domain III (EDIII)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sankaradoss, Arun, Jagtap, Suraj, Nazir, Junaid, Moula, Shefta E., Modak, Ayan, Fialho, Joshuah, Iyer, Meenakshi, Shastri, Jayanthi S., Dias, Mary, Gadepalli, Ravisekhar, Aggarwal, Alisha, Vedpathak, Manoj, Agrawal, Sachee, Pandit, Awadhesh, Nisheetha, Amul, Kumar, Anuj, Bordoloi, Mahasweta, Shafi, Mohamed, Shelar, Bhagyashree, Balachandra, Swathi S., Damodar, Tina, Masika, Moses Muia, Mwaura, Patrick, Anzala, Omu, Muthumani, Kar, Sowdhamini, Ramanathan, Medigeshi, Guruprasad R., Roy, Rahul, Pattabiraman, Chitra, Krishna, Sudhir, Sreekumar, Easwaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736276/
https://www.ncbi.nlm.nih.gov/pubmed/34999210
http://dx.doi.org/10.1016/j.ymthe.2022.01.013

Ejemplares similares

Ejemplares similares